Your search returned 4 results.

Results
	1.	Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma. [electronic resource] by Kurosawa, M Sutoh, E Producer: 20191111 In: Journal of investigational allergology & clinical immunology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study. [electronic resource] by Kurosawa, M Ogawa, E Sutoh, E Producer: 20200713 In: European annals of allergy and clinical immunology vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Familial clustering of hypereosinophilic diseases treated with mepolizumab: a case report from Japan. [electronic resource] by Kurosawa, M Sutoh, Y Sutoh, E Producer: 20210628 In: European annals of allergy and clinical immunology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia. [electronic resource] by Shimizu, Y Kurosawa, M Sutoh, Y Sutoh, E Producer: 20210310 In: Journal of investigational allergology & clinical immunology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)